We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Methicillin-Resistant Infections Spread Like Wildfire

By HospiMedica staff writers
Posted on 29 Aug 2006
Methicillin-resistant Staphylococcus aureus (MRSA) has become the most common cause of skin and soft tissue infections, taking emergency room doctors back to the pre-penicillin days, when skin infections were lanced and drained, according to a new study.

Researchers from the Olive View-University of California Los Angeles Medical Center (OVMC-UCLA, Sylmar, CA, USA) prospectively looked at MRSA infections at 11 metropolitan centers in 2004. More...
Specimens from 422 adult patients treated were cultured at each hospital using standard methods, and those found to be S aureus were sent to the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) for further characterization. More than 75% of all skin and soft tissue infections treated were found to be colonized with S aureus, and 59% overall were methicillin-resistant. By comparison, MRSA was an uncommon cause of skin and soft tissue infections prior to 2000, hovering around 3%, depending on geographic location.

Although resistant to the antibiotic methicillin, most of the MRSA specimens were still susceptible to clindamycin (95%) and fluoroquinolones (60%). All were vulnerable to rifampin and trimethoprim-sulfamethoxazole. Only 6% were susceptible to erythromycin.

Most patients were treated with a combination of incision, drainage, and antibiotics (66%), another 10% received only antibiotics, and 19% underwent incision and drainage alone. Five percent received neither. The most commonly used antibiotics were antistaphylococcal penicillin and cephalosporin (64%). The study was published in the August 17, 2006, edition of the New England Journal of Medicine.

"MRSA is the most-common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage,” concluded Gregory J. Moran, M.D., and colleagues from the OVMC.



Related Links:
Centers for Disease Control and Prevention
UCLA Medical Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.